Erratum: Editor's Note: G-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment(Cancer Res (2010)70 (8695–705) DOI: 10.1158/0008-5472.CAN-10-2318));γ-Tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment

Cancer Research

Volumn 70, Issue 21, 2010, Pages 8695-8705

  Kunnumakkara, Ajaikumar B ^a   Sung, Bokyung ^a   Ravindran, Jayaraj ^a   Diagaradjane, Parmeswaran ^a   Deorukhkar, Amit ^a   Dey, Sanjit ^a   Koca, Cemile ^a   Yadav, Vivek R ^a   Tong, Zhimin ^a   Gelovani, Juri G ^a   Guha, Sushovan ^a   Krishnan, Sunil ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYCLIN D1; CYCLOOXYGENASE 2; GAMMA TOCOTRIENOL; GELATINASE B; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN BCL 2; PROTEIN P53; SURVIVIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; ONCOGENE C MYC; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 78449309277     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-18-1826     Document Type: Erratum

References (39)

1. http://www.cancer.gov/cancertopics/types/pancreatic.
2. Aggarwal BB. Nuclear factor-κB: the enemy within. Cancer Cell 2004; 6:203-8.
3. Arlt A, Gehrz A, Muerkoster S, et al. Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003;22:3243-51.
4. Liptay S, Weber CK, Ludwig L, et al. Mitogenic and antiapoptotic role of constitutive NF-κB/Rel activity in pancreatic cancer. Int J Cancer 2003;105:735-46.
5. Wang W, Abbruzzese JL, Evans DB, et al. The nuclear factor-κ B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5:119-27.
6. Fujioka S, Sclabas GM, Schmidt C, et al. Function of nuclear factor κB in pancreatic cancer metastasis. Clin Cancer Res 2003;9:346-54.
7. Greten FR, Weber CK, Greten TF, et al. Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 2002;123:2052-63.
8. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-42.
9. Kornmann M, Ishiwata T, Itakura J, et al. Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology 1998;55:363-9.
10. Xiong HQ, Abbruzzese JL, Lin E, et al. NF-κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells. Int J Cancer 2004;108:181-8.
11. Yebra M, Filardo EJ, Bayna EM, et al. Induction of carcinoma cell migration on vitronectin by NF-κ B-dependent gene expression. Mol Biol Cell 1995;6:841-50.
12. Aggarwal BB, Sundaram C, Prasad S, Kannappan R. Tocotrienols, the vitamin E of the 21(st) century: its potential against cancer and other chronic diseases. Biochem Pharmacol 2010.
13. Sundram K, Khor HT, Ong AS, Pathmanathan R. Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz(a) anthracene. Cancer Res 1989;49:1447-51.
14. Kamal-Eldin A, Appelqvist LA. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996;31:671-701.
15. Shah SJ, Sylvester PW. γ-Tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor κB activity. Exp Biol Med (Maywood) 2005;230:235-41.
16. Ahn KS, Sethi G, Krishnan K, Aggarwal BB. γ-Tocotrienol inhibits nuclear factor-κB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J Biol Chem 2007;282: 809-20.
17. Hussein D, Mo H. d-Dlta-tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas 2009;38:e124-36.
18. Bachawal SV, Wali VB, Sylvester PW. Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells. BMC Cancer 2010;10:84.
19. Shirode AB, Sylvester PW. Synergistic anticancer effects of combined γ-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFκB signaling. Biomed Pharmacother 2010;64: 327-32.
20. Wali VB, Bachawal SV, Sylvester PW. Combined treatment of γ-tocotrienol with statins induce mammary tumor cell cycle arrest in G1. Exp Biol Med (Maywood) 2009;234:639-50.
21. Samant GV, Sylvester PW. γ-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell Prolif 2006;39:563-74.
22. Mizushina Y, Nakagawa K, Shibata A, et al. Inhibitory effect of tocotrienol on eukaryotic DNA polymerase λ and angiogenesis. Biochem Biophys Res Commun 2006;339:949-55.
23. Wells SR, Jennings MH, Rome C, et al. α-, γ- and δ-tocopherols reduce inflammatory angiogenesis in human microvascular endothelial cells. J Nutr Biochem 2009.
24. Shibata A, Nakagawa K, Sookwong P, et al. Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1α. J Nutr 2008; 138:2136-42.
25. Yam ML, Abdul Hafid SR, Cheng HM, Nesaretnam K. Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages. Lipids 2009;44:787-97.
26. Gysin R, Azzi A, Visarius T. γ-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J 2002;16:1952-4.
27. Yap WN, Zaiden N, Luk SY, et al. In vivo evidence of γ-tocotrienol as a chemosensitizer in the treatment of hormone-refractory prostate cancer. Pharmacology 2010;85:248-58.
28. Kunnumakkara AB, Diagaradjane P, Anand P, et al. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 2009;125:2187-97.
29. Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products. Cancer Res 2007;67:3853-61.
30. Khanbolooki S, Nawrocki ST, Arumugam T, et al. Nuclear factor-κB maintains TRAIL resistance in human pancreatic cancer cells. Mol Cancer Ther 2006;5:2251-60.
31. Yap SP, Julianto T, Wong JW, Yuen KH. Simple high-performance liquid chromatographic method for the determination of tocotrienols in human plasma. J Chromatogr B Biomed Sci Appl 1999; 735:279-83.
32. Kumar KS, Raghavan M, Hieber K, et al. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant γ-tocotrienol. Life Sci 2006;78:2099-104.
33. Harikumar KB, Kunnumakkara AB, Sethi G, et al. Resveratrol, a multi-targeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer 2010;127:257-68.
34. McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp Biol Med (Maywood) 2007;232:523-31.
35. Song BL, DeBose-Boyd RA. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by δ- and γ-tocotrienols. J Biol Chem 2006;281: 25054-61.
36. Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 2004;229:567-85.
37. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 1993;268:11230-8.
38. Ahn KS, Sethi G, Aggarwal BB. Simvastatin potentiates TNF-α- induced apoptosis through the down-regulation of NF-κB-dependent antiapoptotic gene products: role of IκBα kinase and TGF-β-activated kinase-1. J Immunol 2007;178:2507-16.
39. Husain K, Francois RA, Hutchinson SZ, et al. Vitamin E δ-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration. Pharmacology 2009;83:157-63.